Proteomic Research in Peritoneal Dialysis
Peritoneal dialysis (PD) is an established home care, cost-effective renal replacement therapy (RRT), which offers several advantages over the most used dialysis modality, hemodialysis. Despite its potential benefits, however, PD is an under-prescribed method of treating uremic patients. Infectious...
Main Authors: | Mario Bonomini, Francesc E. Borras, Maribel Troya-Saborido, Laura Carreras-Planella, Lorenzo Di Liberato, Arduino Arduini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/15/5489 |
Similar Items
-
A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience
by: Carmela Rago, et al.
Published: (2021-02-01) -
Current Opinion on Usage of L-Carnitine in End-Stage Renal Disease Patients on Peritoneal Dialysis
by: Mario Bonomini, et al.
Published: (2019-09-01) -
METHOD OF LAPAROSCOPIC OMENTOPERITONEOPEXY AS A MEANS FOR PROLONGING EFFECTIVE FILTRATION IN PERITONEAL DIALYSIS
by: Kebkalo A. B., et al.
Published: (2019-04-01) -
THE PERITONEAL DIALYSIS TREATMENT IN DIALYSIS CENTRE NOVO MESTO
by: Mateja Globokar, et al.
Published: (2004-12-01) -
Peritoneal Microbiome in End-Stage Renal Disease Patients and the Impact of Peritoneal Dialysis Therapy
by: Liliana Simões-Silva, et al.
Published: (2020-01-01)